David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$483M |
| 2 |
Biogen
BIIB
|
+$429M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$397M |
| 4 |
LNKD
LinkedIn Corporation
LNKD
|
+$247M |
| 5 |
Union Pacific
UNP
|
+$242M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$632M |
| 2 |
Marathon Petroleum
MPC
|
+$474M |
| 3 |
Meta Platforms (Facebook)
META
|
+$469M |
| 4 |
DuPont de Nemours
DD
|
+$444M |
| 5 |
Phillips 66
PSX
|
+$444M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.61% |
| 2 | Technology | 9.11% |
| 3 | Communication Services | 9.07% |
| 4 | Energy | 8.1% |
| 5 | Financials | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Insulet
PODD
$10.1B
| $20.3M | 0.03% |
537,638
+369,173
| +219% | +$12.4M |
|
627
Vulcan Materials
VMC
$35.8B
| $20.3M | 0.03% |
213,627
-239,130
| -53% | -$23.2M |
|
628
CALL
AbbVie
ABBV
$467B
| $20.2M | 0.03% |
341,300
+120,000
| +54% | +$6.91M |
|
629
Graphic Packaging
GPK
$3.39B
| $20.2M | 0.03% |
1,572,903
+934,434
| +146% | +$12.6M |
|
|
WMGI
630
DELISTED
Wright Medical Group Inc
WMGI
| $20.1M | 0.03% |
829,370
+428,423
| +107% | +$9.28M |
|
631
NXP Semiconductors
NXPI
$56.1B
| $20M | 0.03% |
237,164
-330,697
| -58% | -$28.3M |
|
632
PUT
Coca-Cola
KO
$396B
| $20M | 0.03% |
464,700
+335,000
| +258% | +$14.2M |
|
633
NextEra Energy
NEE
$175B
| $19.9M | 0.03% |
765,560
+1,604
| +0.2% | +$40.6K |
|
634
CALL
General Dynamics
GD
$104B
| $19.8M | 0.03% |
144,100
| – | – |
|
635
SL Green Realty
SLG
$4.15B
| $19.8M | 0.03% |
180,922
+177,173
| +4,726% | +$19.9M |
|
636
Stryker
SYK
$126B
| $19.7M | 0.03% |
212,345
+90,078
| +74% | +$8.62M |
|
637
Newell Brands
NWL
$2.59B
| $19.6M | 0.03% |
444,438
-153,145
| -26% | -$6.7M |
|
638
Teleflex
TFX
$5.86B
| $19.6M | 0.03% |
148,948
+3,475
| +2% | +$452K |
|
639
Gentex
GNTX
$4.97B
| $19.5M | 0.03% |
1,216,678
-5,970
| -0.5% | -$96.5K |
|
640
Lam Research
LRCX
$388B
| $19.5M | 0.03% |
2,451,480
+1,200,500
| +96% | +$9.03M |
|
|
ICPT
641
PUT
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $19.4M | 0.03% |
129,700
+40,700
| +46% | +$6.89M |
|
642
iShares Biotechnology ETF
IBB
$10.7B
| $19.4M | 0.03% |
+171,633
| New | +$18.6M |
|
643
PUT
Palo Alto Networks
PANW
$286B
| $19.1M | 0.03% |
652,200
+83,400
| +15% | +$2.41M |
|
644
PUT
Thermo Fisher Scientific
TMO
$232B
| $19.1M | 0.03% |
134,700
| – | – |
|
|
POT
645
PUT
DELISTED
Potash Corp Of Saskatchewan
POT
| $19.1M | 0.03% |
1,113,700
+820,000
| +279% | +$16.3M |
|
646
Charles River Laboratories
CRL
$14.3B
| $19M | 0.03% |
236,819
+138,774
| +142% | +$10M |
|
647
CALL
Herbalife
HLF
$1.32B
| $19M | 0.03% |
710,000
+660,000
| +1,320% | +$18.3M |
|
648
PUT
PepsiCo
PEP
$197B
| $19M | 0.03% |
190,000
-18,300
| -9% | -$1.83M |
|
649
Pentair
PNR
$10.1B
| $19M | 0.03% |
570,430
-171,938
| -23% | -$6.29M |
|
650
PUT
Macy's
M
$6.1B
| $19M | 0.03% |
541,900
+434,900
| +406% | +$18.8M |
|
Similar funds
David Shaw's Q4 2015 Portfolio in Review
As of Q4 2015, David Shaw held 4,165 positions worth $67.2B, down 1.1% from $67.9B the previous quarter. Its ten largest holdings account for 8.8% of the portfolio.
David Shaw withdrew a net $4.09B in Q4 2015, closing 409 positions and reducing 1,417 holdings. Its most notable exit was Altera Corp, an estimated $236M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 11% a quarter earlier, followed by Technology and Communication Services.
Against the trend, David Shaw opened a new position in Alphabet (Google) Class A worth $417M.
- David Shaw's largest Q4 2015 buy was Alphabet (Google) Class A: 10,723,880 shares worth $417M.
- David Shaw added most to Apple in Q4 2015, an estimated $483M increase.
- David Shaw's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $632M.
- David Shaw fully exited Altera Corp in Q4 2015, selling an estimated $236M.
- David Shaw's ten largest holdings make up 8.8% of its $67.2B portfolio in Q4 2015.
- David Shaw opened 463 new positions and closed 409 in Q4 2015.
- David Shaw's portfolio value fell 1.1% quarter-over-quarter to $67.2B.
Based on D.E. Shaw & Co's 13F filing for Q4 2015, filed 16 Feb 2016.